Converging data from epidemiological and biological research implicate insu
lin-like growth factor (IGF) physiology in the regulation of prostate epith
elial cell proliferation and in the pathophysiology of prostate cancer. Thi
s review (1) outlines elements of IGF physiology, (2) reviews recent eviden
ce that circulating IGF-I level is related to risk of prostate cancer, (3)
provides a hypothesis concerning the biological basis for the relationship
between IGF-1 level and risk of prostate cancer, (4) discusses IGF-I physio
logy in the context of neoplastic progression of prostate cancer, and (5) d
iscusses clinical implications of these lines of research with respect to p
revention and treatment.